XML 83 R56.htm IDEA: XBRL DOCUMENT v3.25.4
REVENUES - ACCOUNTS RECEIVABLES, UNBILLED SERVICES, AND UNEARNED REVENUE (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Accounts Receivable, Allowance for Credit Loss $ (36.4) $ (44.7) $ (32.7)
Gross unbilled services 164.0 160.5  
Less: reserve for unbilled services (7.1) (7.6)  
Contract with Customer, Asset, after Allowance for Credit Loss, Current 156.9 152.9  
Deferred Revenue, Revenue Recognized 129.5 113.0 78.9
Unbilled Services, Allowance for Credit Loss 7.1 7.6 7.5
Allowance for Credit Loss 43.5 52.3 $ 40.2
Accounts Receivable, Credit Loss Expense (Reversal) 4.3 14.6  
Unbilled Services, Credit Loss Expense (Reversal) 0.0 0.1  
Credit Loss Expense (Reversal) 4.3 14.7  
Accounts Receivable, Allowance for Credit Loss, Writeoff (14.3) (2.2)  
Unbilled Services, Allowance for Credit Loss, Write Off 0.8 0.0  
Unbilled Services, Allowance for Credit Loss, Write Off (0.8) 0.0  
Accounts Receivable, Allowance for Credit Loss, Writeoff 15.1 2.2  
Accounts Receivable Foreign Currency Translation Impact 1.7 0.4  
Unbilled Services, Allowance for Credit Loss, Foreign Currency Translation 0.3 0.0  
Allowance For Credit Loss Foreign Currency Translation Impact 2.0 0.4  
Accounts receivable, net 2,103.8 1,944.1  
Diagnostics [Member]      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Accounts Receivable, before Allowance for Credit Loss 1,349.0 1,259.3  
Biopharma Laboratory Services      
Accounts, Notes, Loans and Financing Receivable [Line Items]      
Accounts Receivable, before Allowance for Credit Loss 791.2 729.5  
Accounts Receivable, Allowance for Credit Loss $ (36.4) $ (44.7)